Is Glucagon legal in the US?
Yes, FDA approved for very low blood sugar, and as an aid in gut scans.
Glucagon is FDA-approved for severe hypoglycemia and as a diagnostic aid to relax the gut during imaging. Current products include glucagon for injection kits, Gvoke (ready-to-use injection, approved 2019) and Baqsimi (nasal powder, approved 2019); Novo Nordisk discontinued GlucaGen HypoKit in the US on July 1, 2024. 3451
Yes. Glucagon for injection has been approved for decades. It treats severe hypoglycemia and serves as a diagnostic aid. Baqsimi (nasal) and Gvoke (ready-to-use injection) were both approved in 2019. 345
More on Glucagon
Citations
- Novo Nordisk: GlucaGen HypoKit US discontinuation notice novomedlink.com
- Rickels 2016, Diabetes Care: intranasal glucagon for insulin-induced hypoglycemia in adults with type 1 diabetes doi.org
- FDA 2019: Gvoke (glucagon injection) prescribing information accessdata.fda.gov
- FDA 2019: Baqsimi (glucagon nasal powder) prescribing information accessdata.fda.gov
- Novo Nordisk 2021: GlucaGen (glucagon) HypoKit and Diagnostic Kit prescribing information novo-pi.com
Reference information only, not medical advice. Drawn from the Glucagon article, fact-checked against the cited sources. No dosing anywhere on this site.